New Study Suggests Decipher Prostate Biopsy Test May Help Guide Use of Active Surveillance in Prostate CancerBusiness Wire • 07/27/21
Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global GrowthBusiness Wire • 07/12/21
Veracyte Announces Key Appointments to Executive Leadership Team, Supporting Global ExpansionBusiness Wire • 07/08/21
Veracyte Announces Two Pre-Eminent Physician Appointments, Further Strengthening Medical TeamBusiness Wire • 07/01/21
New Data Published in JAMA Oncology Demonstrate Prognostic Utility of Veracyte's Decipher Prostate Genomic Classifier in Locally Advanced Prostate CancerBusiness Wire • 06/14/21
CORRECTING and REPLACING Veracyte to Present at Upcoming Investor ConferencesBusiness Wire • 06/02/21
Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics GrowthBusiness Wire • 06/01/21
Veracyte Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA SamplesBusiness Wire • 05/26/21
Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic ClassifierBusiness Wire • 05/25/21
Veracyte Announces New Pivotal Clinical Validation Data at ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer DetectionBusiness Wire • 05/19/21
Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD DiagnosisBusiness Wire • 05/14/21
Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic BiopsyBusiness Wire • 05/14/21
Veracyte, Inc. (VCYT) CEO Bonnie Anderson on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/11/21
Veracyte Announces New Data Relating to Prosigna Breast Cancer Test to Be Presented at ESMO Breast Cancer Virtual CongressBusiness Wire • 05/04/21
Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCOBusiness Wire • 04/29/21
Veracyte Announces Publication of Study Showing Robust Performance of Percepta GSC in Improving Lung Cancer DiagnosisBusiness Wire • 04/27/21
Veracyte Announces Data for Pulmonology Portfolio to be Presented at American Thoracic Society 2021 International ConferenceBusiness Wire • 04/19/21